Gene Prediction Tools Market Size & Share 2023 to 2032
Market Size by Component (Software, Service), Application (Drug Discovery & Designing, Diagnostics), End User (Research & Academic Institutes, Biotechnology & Pharmaceutical Companies, Hospital & Clinics).
Report ID: GMI6682
|
Published Date: September 2023
|
Report Format: PDF
Download Free PDF
Authors:
Monali Tayade, Jignesh Rawal
Gene Prediction Tools Market Size
Gene Prediction Market is valued to be USD 104 million in 2022 and is projected to grow at CAGR of 18% and reach USD 541.2 million by the end of 2032. The factors such as rising demand for personalized medicines, increasing advancements in genomic research, increasing adoption of bioinformatics, and growing applications of genomics are surging the growth of the global gene prediction tools.
Gene Prediction Tools Market Key Takeaways
Market Size & Growth
Key Market Drivers
Challenges
Gene prediction tools are computational algorithms and software applications designed to recognise and predict the position and structure of genes inside a DNA sequence. They are also known as gene finding tools or gene annotation tools. These tools are widely used in genomics and bioinformatics to assist researchers in understanding the genetic information contained within an organism's genome.
COVID-19 Impact
Due to the pandemic, there has been a significant increase in genetic research on the SARS-CoV-2 virus, which causes COVID-19. Gene prediction tools played a crucial role in identifying viral genes, mutations, and functional components. Researchers utilized these tools not only to identify potential vaccination candidates but also to assess their effectiveness and safety. As a result, mRNA vaccines and viral vector vaccines were developed with the aid of these tools.
However, as the pandemic unfolded, resource reallocation, lockdowns, and disruptions in research activities led to the postponement or cancellation of other research initiatives unrelated to COVID-19. This, in turn, resulted in a slowdown in the adoption and utilization of gene prediction tools in non-COVID-19 research. Clinical studies that relied on gene prediction algorithms as part of their research methods were particularly affected. Issues such as delayed patient recruitment, sample collection, and data analysis ensued, causing setbacks in drug development and therapeutic research.
Gene Prediction Tools Market Driving Factors
Several factors including rising demand for personalized medicines, increasing advancements in genomic research, increasing adoption of bioinformatics and genomic services, and growing applications of genomics are majorly driving the market demand. The rise of precision medicine emphasizes the importance of identification of specific genes and genetic markers associated with diseases. Gene prediction tools aid in identification of disease-associated genetic variants and enable personalized treatment strategies. In addition to this, the pharmaceutical and biotechnology companies rely on genomics for drug discovery services and development. These tools help in identifying drug targets, disease mechanisms, and predicts drug responses.
Gene Prediction Tools Market Restraining Factors
The gene prediction market faces challenges due to the complexity and variability of data. Genomes exhibit significant variation in terms of size, structure, and complexity among different species. Additionally, the presence of alternative splicing, which generates numerous transcript variants from a single gene, further complicates gene prediction. Accurately predicting splice isoforms is particularly challenging in this context.
Gene Prediction Tools Market Analysis
Based on component, the gene prediction tools market is classified as software and service. Among the components, the software segment accounted for highest market share of 64.5% in 2022. Gene prediction software allows customization of parameters, algorithms, and settings to fit their unique requirements. This flexibility is essential because different organisms and research questions may demand specialized approaches. In addition to this, the software provides privacy and security to the data and analysis. Gene prediction software typically involves a one-time or periodic licensing fee. This cost efficiency is particularly attractive to academic institutions and research laboratories with budget constraints.
Based on application, the gene prediction tools market is classified into drug discovery & designing, diagnostics, and other applications. Drug discovery & designing segment accounted for highest business share in 2022 and is projected to witness growth at CAGR of 18.5%. Gene prediction tools facilitates the identification of potential drug targets. Genes involved in disease pathways or encoding proteins with essential functions in disease development can be targeted for drug development efforts. These tools facilitate researchers to uncover the molecular mechanisms underlying diseases. Researchers gain insights into potential therapeutic intervention points by identifying disease-associated genes and their functions.
Based on the end-user, the gene prediction tools market is segmented into research & academic institutes, biotechnology & pharmaceutical companies, hospitals & clinics, and diagnostic laboratories. In 2022, research & academic institutes segment valued to be USD 48.7 million. Research centers and institutes, often associated with universities or governmental organizations, are primary end-users of gene prediction tools. Research in genomics, genetics, molecular biology, and bioinformatics is a particular area of emphasis for these institutions. Gene prediction tools plays a crucial role in genome annotation, functional genomics studies, and understanding the genetic basis of diseases. Due to increasing demand for personalized medicines and increasing investments in biotechnology and pharmaceutical companies have led to an increase in adoption of gene prediction tools in such industries.
North America gene prediction tools market dominated with business share of 48.4% in 2022. The developed countries such as the United States and Canada, is home to numerous leading research institutions, universities, and biotechnology companies at the forefront of genomics research. Advances in genomics have driven the need for accurate and efficient gene prediction tools. In addition to this, North America has a robust biotechnology sector, with substantial investments in drug discovery, and biomanufacturing. Increasing number of biotechnology and pharmaceutical companies that heavily rely on gene prediction tools for drug development are expected to boost the growth of this.
Gene Prediction Tools Market Share
The key players in the gene prediction tools market are
These companies are implementing several strategies such as collaborations, acquisitions, partnerships, mergers, and product launches to maintain a competitive edge in the industry.
Gene Prediction Tools Industry News:
Gene prediction tools market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:
Click here to Buy Section of this Report
Market Size, By Component
Market Size, By Application
Market Size, By End-user
The above information is provided for the following regions and countries:
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →